-
by uncontrolled proliferation of the plasma cells. Over the last decade there have been several advances in its treatment, such as immunomodulators and proteasome inhibitors, however it remains
-
Deadline 31 May 2024 - 00:00 (Europe/Dublin) Type of Contract Temporary Job Status Full-time Hours Per Week 35 Offer Starting Date 8 Sep 2024 Is the job funded through the EU Research Framework Programme
Enter an email to receive alerts for DateCreated Last 7 Days positions